<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366372">
  <stage>Registered</stage>
  <submitdate>25/05/2014</submitdate>
  <approvaldate>4/06/2014</approvaldate>
  <actrnumber>ACTRN12614000591651</actrnumber>
  <trial_identification>
    <studytitle>Effectiveness of mechanical debridement with scalpel for plantar callosities</studytitle>
    <scientifictitle>The effect of mechanical debridement in patients suffering from plantar callosities on pain and disability</scientifictitle>
    <utrn />
    <trialacronym>EMEDESCA</trialacronym>
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>plantar callosities on foot</healthcondition>
    <conditioncode>
      <conditioncode1>Skin</conditioncode1>
      <conditioncode2>Other skin conditions</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Intervention A: The podiatrist performing the intervention A removes keratin layers of the callus by mechanical debridement with a scalpel blade number 15, seen yellow and hard consistency, until the skin is softer and pink. The procedure is performed in a single session and does not require anesthesia. And subsequent protection with felt or padding if necesary. 
Intervention B: Aplication of keratolytic (salicylic acid) as a patch 3 days without wetting. Cut a piece of patch the size of the lesion to be removed. Apply the dressing over the affected part clean and dry, covering it with a patch. Leave it until the corns or callosities can be removed painlessly using a hot water bath (3 days). The participants remove the patch themselves. The calluses remove by the keratolytic action of salicylic acid. The concentration of salicylic acid is 35 percent.
</interventions>
    <comparator>Standard treatment: application of keratolytic (salicylic acid) patch. Is the same as intervention B.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>The Visual Analogue Scale pain (VAS) is a continuous quantitative variable. This is measurements have been traditionally used for measuring foot pain. It consists of a line of 10 centimeter divided into 10 sections of 0-10 where 0 is no pain and 10 is the maximum tolerable pain</outcome>
      <timepoint>baseline, inmediately after the intervention, 15 and 45 days after</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>The Manchester Foot Pain and Disability Index (MFPDI) is a self-assessment 19-item questionnaire developed in the UK to measure foot pain and disability.The remaining 17 items constitute three constructs (sub-scales): functional limitation (10 items), pain intensity (5 items) and concern with personal appearance (2 items). Each of the 17 statements has a 3-category response structure: none of the time = 0, on some days = 1 and on most/every day(s) = 2. The MFPDI has been validated in middle-aged and older populations and has been used as an outcome measure both in large population- based surveys and in clinical studies, including randomised controlled trials. The MFPDI has also been used in studies of various diseases with foot manifestations including systemic sclerosis, EhlersDanlos syndrome and rheumatoid arthritis.</outcome>
      <timepoint>Baseline, 15 and 45 days after intervention</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>The short form Health Survey (SF-12) is a general health questionnaire.The 12 questions that comprise measured eight dimensions (variables) of quality of life related to health and two abstract components, obtained by applying an algorithm that transforms scores typifies subjects and making them directly comparables
1) Physical Function (PF) 2) Physical role (PR)  3) bodily pain (BP) 4) General Health (GH) 5) Vitality (VT): 6) social functioning (SF): 7) Role emotional (RE) 8) Mental Health (MH) 

</outcome>
      <timepoint>Baseline and 45 days after the intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients with plantar callosities or corns on forefoot area, with one or more of pain in forefoot area. The participants are patients attending the Teaching Care Unit (UDA) of the University of Malaga.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>55</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnant patients, patients with neurovascular corns, patients diagnosed with rheumatic diseases, patients with inflamatory or neuritis, patients with cognitive disorders who do not understand the questionnaries, patients with a history of traumatic injuries, patients with peripheral neuropathy or peripheral vascular disease, patients allergic to salicylic acid, salicylates or any component of the drug</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>The sample was calculated with an effect=0.5, alpha=0.05 and power=0.95, resulting in 34 patients for each group intervention.  It is planned to used in the study of the statistical analysis the Statistical Package for Social Sciences (SPSS) version 21.0 </statisticalmethods>
    <masking1>False</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>31/03/2014</anticipatedstartdate>
    <actualstartdate>31/03/2014</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>68</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Active, not recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Malaga</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of Malaga</primarysponsorname>
    <primarysponsoraddress>Arquitecto Francisco Penalosa (Ampliacion Campus Teatinos)
29071 Malaga</primarysponsoraddress>
    <primarysponsorcountry>Spain</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Irene Garcia Paya</fundingname>
      <fundingaddress>Orquidea, 29
29190 
Malaga</fundingaddress>
      <fundingcountry>Spain</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is a randomized controlled trial in patients with plantar callosities and corns, with pain in the forefoot, which aims to determine the effectiveness of the mechanical corn debridement. It is hoped that information gathered from this project will help to contribute to the body of knowledge to an optimal podiatry treatment aproach to plantar callosities</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>CEUMA: University of Malaga Ethics Committee</ethicname>
      <ethicaddress>Boulevar Louis Pasteur, Campus Universitario de Teatinos
Malaga
29071</ethicaddress>
      <ethicapprovaldate>27/02/2014</ethicapprovaldate>
      <hrec>2013-0012-H</hrec>
      <ethicsubmitdate>22/04/2013</ethicsubmitdate>
      <ethiccountry>Spain</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mrs</title>
      <name>Irene Garcia-Paya</name>
      <address>Facultad de Ciencias de la Salud
Arquitecto Francisco Penalosa (Ampliacion Campus de Teatinos)
29071 Malaga</address>
      <phone>+34 667629289   +34 951952876</phone>
      <fax />
      <email>idgarcia@uma.es</email>
      <country>Spain</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Irene Garcia-Paya</name>
      <address>Facultad de Ciencias de la Salud
Arquitecto Francisco Penalosa (Ampliacion Campus de Teatinos)
29071 Malaga</address>
      <phone>+34 951952876</phone>
      <fax />
      <email>idgarcia@uma.es</email>
      <country>Spain</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Irene Garcia-Paya</name>
      <address>Facultad de Ciencias de la Salud
Arquitecto Francisco Penalosa (Ampliacion Campus de Teatinos)
29071 Malaga</address>
      <phone>+34 951952876</phone>
      <fax />
      <email>idgarcia@uma.es</email>
      <country>Spain</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mrs</title>
      <name>Irene Garcia-Paya</name>
      <address>Facultad de Ciencias de la Salud
Arquitecto Francisco Penalosa (Ampliacion Campus de Teatinos)
29071 Malaga</address>
      <phone />
      <fax />
      <email />
      <country>Spain</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>